ESMO Conference Platform

ELCC 2022 Onsite and Online Congress

Final Programme PDF Advanced Search

11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00

Club A

14:15(1h)Mini Oral session 2
16:00(1h 30m)Personalised treatment of lung cancer brain metastases

Congress Hall

16:00(1h 30m)Thymic tumours
13:30(35m)Welcome to ELCC 2022 and Heine H. Hansen Award 2022 Keynote lecture
14:15(1h 30m)What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC

Forum Hall

18:15(1h 30m)Bristol Myers Squibb - Breaking barriers in thoracic cancers: The expanding possibilities for patients with I-O treatment
11:30(1h 30m)Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC
16:00(1h 30m)New insights in the treatment of geriatric patients
14:15(1h 30m)Not so small anymore: New therapies and cutting-edge science to guide the care of patients with small cell lung cancer

South Hall 2

11:30(1h 30m)Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC
14:15(1h 30m)Implementation of screening programmes in Europe
18:15(1h 30m)Medscape Oncology Global - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
16:00(1h 30m)Telemedicine in lung cancer: What to do in 2022?